![Journal cover image](https://secure.syndetics.com/index.aspx?isbn=/lc.gif&issn=0002-9394&client=dukeuniv)
Bull's-eye maculopathy associated with quinacrine therapy for malaria.
Publication
, Journal Article
Browning, DJ
Published in: Am J Ophthalmol
March 2004
PURPOSE: To report a side effect of quinacrine therapy for malaria. DESIGN: Case report. METHODS: Review of clinical chart and photographs. SETTING: Private retina practice. RESULTS: A patient developed a bilaterally symmetric bull's-eye maculopathy 45 years after taking quinacrine for 18 months as prophylaxis against malaria. Progression of the clinical picture was documented over 15 years of follow-up. The clinical picture was identical to that of chloroquine and hydroxychloroquine maculopathy. CONCLUSIONS: Low dosages of quinacrine used for malaria prophylaxis can be associated with a delayed, severe maculopathy indistinguishable from chloroquine maculopathy in certain patients.
Duke Scholars
Published In
Am J Ophthalmol
DOI
ISSN
0002-9394
Publication Date
March 2004
Volume
137
Issue
3
Start / End Page
577 / 579
Location
United States
Related Subject Headings
- Visual Acuity
- Retinal Diseases
- Quinacrine
- Ophthalmology & Optometry
- Middle Aged
- Male
- Malaria, Vivax
- Humans
- Fluorescein Angiography
- Electroretinography
Citation
APA
Chicago
ICMJE
MLA
NLM
Browning, D. J. (2004). Bull's-eye maculopathy associated with quinacrine therapy for malaria. Am J Ophthalmol, 137(3), 577–579. https://doi.org/10.1016/j.ajo.2003.08.047
Browning, David J. “Bull's-eye maculopathy associated with quinacrine therapy for malaria.” Am J Ophthalmol 137, no. 3 (March 2004): 577–79. https://doi.org/10.1016/j.ajo.2003.08.047.
Browning DJ. Bull's-eye maculopathy associated with quinacrine therapy for malaria. Am J Ophthalmol. 2004 Mar;137(3):577–9.
Browning, David J. “Bull's-eye maculopathy associated with quinacrine therapy for malaria.” Am J Ophthalmol, vol. 137, no. 3, Mar. 2004, pp. 577–79. Pubmed, doi:10.1016/j.ajo.2003.08.047.
Browning DJ. Bull's-eye maculopathy associated with quinacrine therapy for malaria. Am J Ophthalmol. 2004 Mar;137(3):577–579.
![Journal cover image](https://secure.syndetics.com/index.aspx?isbn=/lc.gif&issn=0002-9394&client=dukeuniv)
Published In
Am J Ophthalmol
DOI
ISSN
0002-9394
Publication Date
March 2004
Volume
137
Issue
3
Start / End Page
577 / 579
Location
United States
Related Subject Headings
- Visual Acuity
- Retinal Diseases
- Quinacrine
- Ophthalmology & Optometry
- Middle Aged
- Male
- Malaria, Vivax
- Humans
- Fluorescein Angiography
- Electroretinography